Synlogic ^Competitor

Synlogic is a biopharmaceutical company based in Cambridge, Massachusetts, focused on developing novel therapeutics for serious diseases, particularly rare and genetic metabolic disorders. The company specializes in synthetic biology, creating living medicines known as Synthetic Biotics. These therapeutics are designed to address the underlying causes of diseases in innovative ways.

The company's proprietary platform combines molecular biology, microbial engineering, and physiology to develop drug candidates for conditions such as phenylketonuria (PKU), homocystinuria (HCU), enteric hyperoxaluria, and gout. Synlogic also explores treatments for liver disease, inflammatory and immune disorders, and cancer. Their development process includes assessing disease mechanisms, designing biotic prototypes, and building Synthetic Biotics for oral administration, enhancing patient experience. Synlogic collaborates with pharmaceutical and biotechnology companies to advance its drug development efforts.